TrialEuropean urology oncology2018

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.

Francesco Gatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.